Here's the latest Publication Roundup! In these monthly posts, we'll feature recent papers that cited Design-Expert® or Stat-Ease® 360 software. Please submit your paper to us if you haven't seen it featured yet!
Implementation of the QbD Approach to the Analytical Method Development and Validation for the Estimation of the Treprostinil Injection Dosage Form by RP-HPLC
ACS Omega, 2025
Authors: Narasimha Raju Alluri, Mallikharjuna Rao Bandlamudi, Sujatha Kuppusamy, Shabna Roupal Morais
Mark's comments: This one hits the spot for me by deploying a solid central composite design, being succinct in presenting only the most relevant statistics on significance and model fits, showing compelling 3D pictures, and providing the data via a link to supplementary material. It is great to see how response surface methods done with Stat-Ease software led to a “novel, precise, sensitive, stable, and cost-effective” analytical method. Well done!
Be sure to check out this important study, and the other research listed below!
Here's the latest Publication Roundup! In these monthly posts, we'll feature recent papers that cited Design-Expert® or Stat-Ease® 360 software. Please submit your paper to us if you haven't seen it featured yet!
Material-sparing degradation-kinetics model for thermolabile drug stability assessment during twin-screw melt granulation – insights with gabapentin
International Journal of Pharmaceutics, Volume 674, 15 April 2025, 125421
Authors: Adwait Pradhan, Fengyuan Yang, Kapish Karan, Thomas Durig, Quyen Schwing, Brian Haight, Mark Costello, Mark Anderson, Feng Zhang
Mark's comments: "It was a pleasure to help Adwait, et al apply response surface methods (RSM) for process optimization of twin-screw melt granulation to mininimze degradation of life-enhancing drugs such as gabapentin."
Be sure to check out this important study, and the other research listed below!
Next in our 40th anniversary “Ask an Expert” blog series is John "Jay" Davies, who's an absolute rock star when it comes to teaching and implementing DOE. He's lent us his expertise before - see this talk from our 2022 Online DOE Summit - and he shared an anecdote with our statistical experts about how he approaches switching to DOE methods when working with new groups in the Army. He kindly agreed to let us publish it as part of this series.
For the past 14 years, I’ve been a Research Physicist with the U.S. Army DEVCOM Chemical Biological Center at Aberdeen Proving Grounds, MD as a member of the Decontamination Sciences Branch, which specializes in developing techniques/chemistries to neutralize chemical warfare agents. I’m dedicated to applied statistical analysis ranging from multi-laboratory precision studies to design of experiments (DOE). The Decontamination Sciences Branch has been integrating DOE methods into many of their chemical agent decontamination research programs.
I’m happy to report that the DOE methods here at the Chemical Biological Center are really catching on. I collaborated on 24 DOEs from 2014 through 2021. Then, in 2021-22, we completed 26 DOEs across 10 different programs. I’ve been doing a lot of mixture-process DOEs with the Bio Sciences groups for synthetic biology and bio manufacturing applications, and once the other groups saw the information that we were getting from just a single day’s worth of data, they too wanted to try DOE.
Lately, I’ve changed the formula that I use for the initial consultations when visiting a group that has expressed an interest in DOE but has never used DOE before. Previously we’d go right into their project, and I’d tell them how we might construct a DOE for their application. However, I’ve found that it’s too much of a culture shock if we go right into talking about what a DOE for their application might look like. Instead, especially if I’m working with a group that has no DOE experience at all, I now devote about 1 hour to discuss DOE methods in general before we even mention their actual application. In this discussion, I reveal the major differences that they are going to see with a DOE, which are:
Recently, I was following this format with a group that had never used DOE before. We had a great back-and-forth dialog as I went through the bullets above and explained a bit about each point. They asked many questions and were really following along. Then, after about an hour we got into their application and I just sketched out a prototype quadratic mixture-process DOE that I thought would give them a good idea of what the initial DOE might look like, with 30 samples in total. I then went over what some simulated outputs for the DOE generated prediction model might look like. At this point one of them stopped me and with a very perplexed look on his face, said “hold on, hold on…wait a minute here. Are you telling us that if we run just those 30 samples, we would be able to predict the optimal formulation and the optimal process setting for this system?“
This scientist had been following along, asking questions and really absorbing the information in the past hour as we walked through the DOE basics, but I could see that at that moment things were just sinking in. He realized the ramifications of what we had just discussed – typically, this group might have had to run several hundreds of samples to characterize similar systems, but with DOE they would only need about 30 samples. I responded to his question saying, “Yes that’s exactly what I’m telling you. We’ve run dozens of these mixture-process DOEs, many of them much more complex than this system, and they do work.” This individual, a mid-career researcher, then responded, “How is it possible that we have not heard of this stuff before?” I told him, “I can’t give you a good answer to that one.”
And there you have it! Let us know if you want to talk about saving time & money with DOE: our statistical experts and first-in-class software make it easier than ever.
DISTRIBUTION STATEMENT A. Approved for Public Release: Distribution is Unlimited
Here's the latest Publication Roundup! In these monthly posts, we'll feature recent papers that cited Design-Expert® or Stat-Ease® 360 software. Please submit your paper to us if you haven't seen it featured yet!
Mark's comment: Make sure to check out article #10, where the authors deploy response surface methods (with lots of impressive 3D plots!) to produce an eco-friendly material for civil engineering.
Next in our 40th anniversary “Ask an Expert” blog series is Leonard “Len” Rubinstein, a Distinguished Scientist at Merck. He has over 3 decades of experience in the pharmaceutical industry, with a background in immunology. Len has spent the last couple of decades working on bioanalytical development, supporting bioprocess and clinical assay endpoints. He’s also a decades-long proponent of design of experiments (DOE), so we reached out to learn what he has to say!
When did you first learn about DOE? What convinced you to try it?
I first learned about DOE in 1996. I enrolled in a six-day training course to better understand the benefits of this approach in my assay development.
What convinced you to stick with DOE, rather than going back to one-factor-at-a-time (OFAT) designs?
Once I started using the DOE approach, I was able to shorten development time but, more importantly, gained insights into understanding interactions and modeling the results to predict optimal parameters that provided the most robust and least variable bioanalytical methods. Afterward, I could never go back to OFAT!
How do you currently use & promote DOE at your company?
DOE has been used in many areas across the company for years, but it has not been explicitly used for the analytical methods supporting clinical studies. I raised awareness through presentations and some brief training sessions. Afterward, after my management adopted it, I started sponsoring the training. Since 2018, I have sponsored four in-person training sessions, each with 20 participants.
Some examples of where we used DOE can be found at the end of this interview.
What’s been your approach for spreading the word about how beneficial DOE is?
Convincing others to use DOE is about allowing them to experience the benefits and see how it’s more productive than using an OFAT approach. They get a better understanding of the boundaries of the levels of their factors to have little effect on the result and, more importantly, sometimes discard what they thought was an important factor(s) in favor of those that truly influenced their desired outcome.
Is there anything else you’d like to share to further the cause of DOE?
It would be beneficial if our scientists were exposed to DOE approaches in secondary education, be it a BA/BS, MA/MS, or PhD program. Having an introduction better prepares those who go on to develop the foundation and a desire to continue using the DOE approach and honing their skills with this type of statistical design in their method development.
And there you have it! We appreciate Len’s perspective and hope you’re able to follow in his footsteps for experimental success. If you’re a secondary education teacher and want to take Len’s advice about introducing DOE to your students, send us a note: we have “course-in-a-box” options for qualified instructors, and we offer discounts to all academics who want to use Stat-Ease software or learn DOE from us.
Len’s published research:
Whiteman, M.C., Bogardus, L., Giacone, D.G., Rubinstein, L.J., Antonello, J.M., Sun, D., Daijogo, S. and K.B. Gurney. 2018. Virus reduction neutralization test: A single-cell imaging high-throughput virus neutralization assay for Dengue. American Journal of Tropical Medicine and Hygiene. 99(6):1430-1439.
Sun, D., Hsu, A., Bogardus, L., Rubinstein, L.J., Antonello, J.M., Gurney, K.B., Whiteman, M.C. and S. Dellatore. 2021. Development and qualification of a fast, high-throughput and robust imaging-based neutralization assay for respiratory syncytial virus. Journal of Immunological Methods. 494:113054
Marchese, R.D., Puchalski, D., Miller, P., Antonello, J., Hammond, O., Green, T., Rubinstein, L.J., Caulfield, M.J. and D. Sikkema. 2009. Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific anti-pneumococcal antibodies in human serum. Clinical and Vaccine Immunology. 16(3):387-396.